newsfilter
← Latest News
Business Wire·

Aptorum Group Announces 1-for-10 Reverse Stock Split

Regulatory News: Aptorum Group Limited (NASDAQ:APM, PARIS:APM) (the "Company") a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune and infectious diseases, today